abstract |
The present invention relates to human interleukin-15 (IL-15) variants having therapeutic and diagnostic uses and methods of making the same. The invention also provides fusion proteins comprising human IL-15 variants. Methods of stimulating or inhibiting an immune response in mammals and methods of using IL-15 variants or fusion proteins of such IL-15 variants to treat disorders (eg, cancer) are also provided. |